N
Norlase
Emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease
About Norlase
Norlase is a pioneering startup in the medical technology sector, specializing in the production of portable laser devices for ophthalmic treatments. The company's flagship products include ECHO, LION, and LEAF, each offering unique features that enhance treatment flexibility and practice efficiency.
ECHO is the world's first truly portable pattern laser, combining Norlase's ultra-compact laser engine with industry-first MEMS pattern technology. This integrated design eliminates the need for bulky tables and cumbersome cables, offering true portability.
LION is an indirect ophthalmoscope integrated with a green laser source, creating a first-of-its-kind treatment device. It is battery-powered, utilizes a wireless user interface, and has voice control of parameters, providing the ultimate in portability and treatment flexibility.
LEAF is a unique green laser photocoagulator that attaches directly to an existing slit lamp, eliminating the need for external fibers, carts, or counter space.
Norlase's clients are primarily healthcare providers in the ophthalmology sector. The company operates in the medical technology market, a sector known for its high growth potential and demand for innovative solutions.
Norlase's business model is based on the sale of its innovative laser devices. By offering portable, efficient, and user-friendly solutions, Norlase has positioned itself as a leader in the ophthalmic laser technology market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Ballerup, Denmark
- Employees
- 73
- Open positions
- None listed
- Dealroom signal
- 85.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Laser Technology, Spinout, Nordic Rising Star 2022, Climate Efficiency, Eitclimatecleantech, Seal of Excellence EC, Horizon Europe, DT and LS
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Feb 2025 | $22M | — | European Investment Bank | ↗ |
| GROWTH EQUITY VC✓Equity / VC | Jun 2023 | $11M | — | West Hill Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Norlase is 8.2K monthly website visits, down 48.8% over the last three months. Norlase's team grew 9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
GleechiScalable virtual reality training platform for industries |
Stockholms kommun, Sweden | Operational | 7 | — | — |
Alcyon PhotonicsPhotonic integrated circuit designs for multiple industries |
Madrid, Spain | Operational | |||
Corify CareNon-invasive, real-time global cardiac arrhythmia mapping system |
Madrid, Spain | Operational | |||
Atrian MedicalRestoring Rhythm through Science |
Galway, Ireland | Operational | |||
BiomimXDeveloping beating organs-on-chip platforms as in vitro pre-clinical models to improve the drug development process |
Milan, Italy | Operational | |||
CroivalveTreating Heart Valve Disease |
Dublin, Ireland | Operational | |||
CapiTainerMicrosampling devices for accurate at-home biological sample collection |
Solna kommun, Sweden | Operational | |||
CerenionMedical device company providing AI-based software for monitoring of brain function in intensive care |
Oulu, Finland | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Horizon 2020 FET (Future and Emerging Technologies)
Innovation Fund Denmark
European Innovation Council
Series B and later3 investors entered at this stage
Nordic Secondary Fund
West Hill Capital
European Investment Bank
Other known investors4 additional known investors
Technical University of Denmark
London BioScience Innovation CentreMarket Maturation Fund
- NKNiels Korsholm
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Norlase on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Norlase’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







